ClinicalTrials.gg
RecruitingNCT07151534Updated Sep 17, 2026

Body Awareness, Trunk Stability, and Arm Function in MS

An observational study in Multiple Sclerosis, sponsored by Hacettepe University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 10 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by Hacettepe University · Observational

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 3 months later.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
50
Ages
10 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 23 studies in Multiple Sclerosis by Hacettepe University — 6 open to participants now, 6 under way, none of them phase 3. Multiple Sclerosis · Hacettepe University.

Started
2025
with 2 others
Observational
8 of 23
2 open now
Registered
15th of 23
by date

Among the 23 studies in Multiple Sclerosis by Hacettepe University, this one is one of 3 that started in 2025, is one of 8 observational ones, and was the 15th registered.

By phase

23 studies; the count open now beside each. This study's row is marked.

No phase15 · 4 open
Observationalthis study8 · 2 open

By the year they started

First in 2015; this study’s year is marked. 3 started in 2025.

Size and results

Median enrollment 34 across the 15 interventional studies, 56 across the 8 observational. Of the 13 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 23 studies in Multiple Sclerosis by Hacettepe University, or all of them as a file.
02

Study summary

The aim of this study is to investigate the relationship between body awareness, trunk stabilization, and upper extremity functionality in patients with Multiple Sclerosis (MS).

Hypotheses of the study:

H1: There is a significant relationship between body awareness and upper extremity functionality in patients with MS.

H2: There is a significant relationship between body awareness and trunk stabilization in patients with MS.

H3: Body awareness is reduced in patients with MS compared to healthy individuals.

H4: Trunk stabilization is reduced in patients with MS compared to healthy individuals.

H5: Upper extremity functionality is reduced in patients with MS compared to healthy individuals.

Read the detailed description

Patients' demographic and disease-specific information will be recorded. Subsequently, body awareness, upper extremity functionality, and trunk stabilization will be assessed.

03

Conditions studied

  • Multiple Sclerosis

Browse trials for

Keywords

  • body awareness
  • upper extremity
  • trunk stabilization
  • multiple sclerosis
04

Who can participate

Ages eligible
10 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

MS patients and healthy subjects with inclusion criteria

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with Multiple Sclerosis (MS) by a neurologist according to the McDonald criteria
  • Aged 18 years or older
  • Expanded Disability Status Scale (EDSS) score ≤ 5
  • (MMSE) score ≥ 24

    • A control group consisting of healthy individuals matched with MS patients in terms of age and sex

Exclusion criteria

Exclusion Criteria:

  • Having a neurological disorder other than MS
  • Having experienced a relapse and/or used in the past 3 months
  • Having an orthopedic/systemic condition affecting the upper extremities or trunk
  • Being pregnant
  • Refusing to participate or not providing written

    • Healthy individuals who have an orthopedic/systemic condition affecting the upper extremities or trunk, who are pregnant, or who do not agree to participate and provide written informed consent will be excluded.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
50 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Multiple Sclerosis

    Diagnosed with Multiple Sclerosis (MS) by a neurologist according to the McDonald criteria, aged 18 years or older, Expanded Disability Status Scale (EDSS) score of ≤ 5, Mini-Mental State Examination score of 24 or higher will be included in the study.

  • Healthy

    A control group consisting of healthy individuals matched with MS patients by age and sex will be included in the study.

06

What researchers measure

Primary outcomes

  1. Body Awareness Questionnaire

    To assess body awareness, the Body Awareness Questionnaire will be used.This questionnaire consists of 18 items, each scored on a scale from 1 to 7, and evaluates body awareness. Higher scores indicate better body awareness. The Turkish version has been validated and found to be reliable.

    Time frame: up to 6 months

  2. Body Awareness Rating Questionnaire

    To assess body awareness,the Body Awareness Rating Questionnaire will be used. Body Awareness Rating Questionnaire:This questionnaire includes 24 items across 4 domains: function, mood, feeling/sensation, and awareness. Higher scores indicate better body awareness. The Turkish version has been validated and shown to be reliable.

    Time frame: up to 6 months

  3. Upper Extremity Functionality-Grip strength

    Grip strength will be measured with a Jamar dynamometer. It will be performed three times bilaterally, and average values (kg) will be recorded.

    Time frame: up to 6 months

  4. Upper Extremity Functionality-Pinch strength

    Pinch strengths will be assessed using a Baseline pinch gauge. It will be performed three times bilaterally, and average values (kg) will be recorded.

    Time frame: up to 6 months

  5. Upper Extremity Functionality-Nine Hole Peg Test (9HPT)

    The 9HPT will evaluate hand dexterity by timing how quickly participants place and remove nine pegs. Each hand will be tested three times. It will be recorded in seconds. An average time ≥33.3 seconds will indicate dysfunction in MS patients.

    Time frame: up to 6 months

  6. Trunk Stabilization- Trunk Impairment Scale (TIS),

    Trunk stabilization will be evaluated using the TIS.TIS: Assesses static/dynamic balance and trunk coordination (17 items, 0-23 points).

    Time frame: up to 6 months

  7. Trunk Stabilization-plank endurance test

    Trunk stabilization will be evaluated using the plank endurance test. The test measures core endurance. Plank test: Time held in forearm plank recorded. It will be recorded in seconds.

    Time frame: up to 6 months

  8. Trunk Stabilization-side bridge test

    Trunk stabilization will be evaluated using the side bridge test. The test measures core endurance Time held in side plank on both sides recorded.It will be recorded in seconds.

    Time frame: up to 6 months

  9. Trunk Stabilization-Modified Biering-Sorensen

    Trunk stabilization will be evaluated using the Modified Biering-Sorensen test. The test measures core endurance. Time holding trunk in horizontal position prone over table edge. It will be recorded in seconds.

    Time frame: up to 6 months

  10. Trunk Stabilization-Trunk flexor test

    Trunk stabilization will be evaluated using the Trunk flexor test test.The test measures core endurance. Time maintaining 60° trunk flexion with knees/hips at 90°. It will be recorded in seconds.

    Time frame: up to 6 months

  11. Trunk Stabilization-Sit up test

    The 30-second Sit-up Test measures core strength. The person lies on their back with knees bent and feet on the floor. They do as many sit-ups as possible in 30 seconds, keeping proper form. The score is the number of correct sit-ups completed.

    Time frame: up to 6 months

  12. Trunk Stabilization-Modifiye push up test

    The 30-second Modified Push-up Test measures core strength. The person starts in a push-up position but with knees on the floor. They perform as many push-ups as possible in 30 seconds, keeping the body straight and lowering the chest close to the ground. The score is the number of correct push-ups completed.

    Time frame: up to 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2025 (actual). Primary completion is estimated for Dec 2026, 16 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 6, 2025
First posted
Sep 3, 2025
StartActual
Aug 6, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Jan 1, 2027
Last update
Sep 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07151534
Responsible party
Güngör Beyza ÖZVAR (Principal Investigator, Hacettepe University) — Principal investigator
First posted
Sep 3, 2025
Start date
Aug 6, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Sep 17, 2026

Study contacts

Güngör Beyza Özvar Şenöz
Contact
beyzaozvar@gmail.com
5053888617 ext. +90
Muhammed Kılınç
principal investigator · Hacettepe University
Özge Onursal Kılınç
study director · Hacettepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion